相关实验视频

Updated: Mar 6, 2026

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

通过调节PANoptosis,ABT-737有效地抑制肝细胞癌细胞活性

Bi Deng¹, Xuefeng Jin², Dongmei Ye³

¹Drug Clinical Trial Office, Guangxi Academy of Medical Sciences and the People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, 530021, Guangxi, P.R. China.

Discover oncology

|March 5, 2026

概括

ABT-737通过诱导PANoptosis,一种被编程的细胞死亡过程,有效地抑制肝细胞癌 (HCC). 这项研究揭示了ABT-73737的存在.

科学领域:

在瘤学瘤学.
细胞生物学细胞生物学
分子医学是分子医学.

背景情况:

肝细胞癌 (HCC) 是全球癌症死亡的主要原因.
作为BCL-2家族的抗体,ABT-737具有抗癌潜力.
在HCC中ABT-737诱导PANoptosis的作用尚不清楚.

研究的目的:

研究ABT-737在HCC细胞中诱导PANoptosis的能力.
阐明ABT-737影响HCC扩散,迁移和入侵的机制.
在HCC模型中评估ABT-737的治疗潜力.

主要方法:

用ABT-737和途径抑制剂治疗HCC细胞系 (SK-HEP-1,BEL-7402).
细胞活力,增殖,迁移和入侵的评估.
流细胞计用于细胞死亡分析.
异种移植小鼠模型,以评估体内疗效.
对与PANoptosis相关的蛋白质表达的西部斑点分析.

主要成果:

根据剂量,ABT-737抑制了HCC的扩散,迁移和入侵.
ABT-737诱导了显著的亡,亡和亡,统称为PANoptosis.
在体内研究显示,ABT-737治疗减少了瘤生长.
西方斑点证实了对亡,亡和亡标记物的上调.

结论:

通过诱导PANoptosis,ABT-737在HCC中表现出强大的抗瘤活性.
ABT-737代表了一种有前途的治疗策略,用于肝细胞癌治疗.

关键词:

在ABT-73737中使用ABT-737 细胞灭亡 (apoptosis) 是一种死亡的过程.Bcl-2 的使用方法.肝细胞癌是肝细胞癌.尸体灭 (Necroptosis) 是一种死亡的过程.这就是PANoptosis.热灭菌的发生.

更多相关视频

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines

Published on: April 18, 2025

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

相关概念视频

Inhibition of Cdk Activity

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...